Baxter International Inc.
BAXBaxter International Inc. is a global healthcare company specializing in medical products and services, including dialysis, intravenous solutions, and biopharmaceuticals. Founded in 1931, the company focuses on supporting patient care through innovative therapies and medical devices across hospitals, clinics, and homes worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| January 2, 2026 | $0.01 | 2025-11-28 | 2025-11-28 |
| October 1, 2025 | $0.17 | 2025-08-29 | 2025-08-29 |
| July 1, 2025 | $0.17 | 2025-05-30 | 2025-05-30 |
| April 1, 2025 | $0.17 | 2025-02-28 | 2025-02-28 |
| January 2, 2025 | $0.17 | 2024-11-29 | 2024-11-29 |
Dividends Summary
- Consistent Payer: Baxter International Inc. has rewarded shareholders with 81 dividend payments over the past 22 years.
- Total Returned Value: Investors who held BAX shares during this period received a total of $23.10 per share in dividend income.
- Latest Payout: The most recent dividend of $0.01/share was paid 21 days ago, on January 2, 2026.
- Yield & Schedule: BAX currently pays dividends quarterly with an annual yield of 2.65%.
- Dividend Growth: Since 2004, the dividend payout has decreased by 98.3%, from $0.58 to $0.01.
Company News
The global sodium chloride injection market is projected to grow from USD 544.12 million in 2025 to USD 870.21 million by 2032, with a CAGR of 6.93%. Growth is driven by clinical practice migration from inpatient to outpatient care, manufacturing modernization including modular aseptic technologies, and innovations in packaging and dosing formats...
Law firm investigating potential securities misconduct for Baxter International and Molina Healthcare following class action complaints alleging misleading statements about product safety and financial performance.
A class action lawsuit has been filed against Baxter International for allegedly misleading investors about systemic defects in their Novum LVP medical devices, which potentially exposed patients to serious injury risks.
A class action lawsuit has been filed against Baxter International for allegedly misleading investors about systemic defects in their Novum LVP medical devices, which potentially exposed patients to serious risks.
Global syringe pumps market projected to grow from $4.58 billion in 2025 to $6.29 billion by 2032, driven by technological advancements in precision infusion therapy, digital health systems, and IoT integration.
